[Influenza vaccination of risk patients with trivalent split virus vaccine and subunit vaccine].
D000917:Antibody Formation; D001249:Asthma / Q000276:immunology*; D006801:Humans; D007252:Influenza Vaccines / Q000009:adverse effects / Q000276:immunology*; D008176:Lung Volume Measurements; D010366:Peak Expiratory Flow Rate
D007252:Influenza Vaccines
Influenza-Impfung von Risikopatienten mit trivalenter Spaltund Subunitvakzine.